KDR Biotech

KDR Biotech is a South Korean biotechnology company primarily focused on the development and distribution of research reagents, diagnostic kits, and therapeutic antibodies. The company specializes in the production of high-quality recombinant proteins and monoclonal antibodies targeting key pathways in oncology and immunology, such as the VEGF and PD-1/PD-L1 axes. In addition to its internal R&D efforts, KDR Biotech serves as a significant distributor for global life science brands in the Korean market, providing essential tools for genomic and proteomic research. Their business model combines the commercialization of diagnostic solutions with the early-stage development of novel biologics.